AGP Executive Report
Last update: 5 hours agoParaguay Dengue Watch: Paraguay’s Ministry of Public Health reports dengue remains stable, averaging 102 notifications per week, with only three new confirmed cases in SE 25–27 and no recent hospitalizations or deaths; cumulative cases reached 288 as of July 18, with DENV-1 identified and the Limpio outbreak showing a sharp decline. Neurology Burden in the Americas: A new Lancet Regional Health—Americas study says nearly 470 million people in the region (about 2 in 5) live with neurological disorders, shifting the burden from premature death toward long-term disability—raising demand for prevention, rehabilitation, and long-term care. Paraguay’s Investment-Grade Signal: Moody’s reaffirmed Paraguay’s Baa3 investment-grade rating with a stable outlook, citing credible monetary policy and political stability. Maquila Jobs and Exports: Paraguay’s maquila exports hit US$717 million in the first half of 2026, up 25% year-on-year, creating 1,923 new jobs, led by automotive parts, clothing, and chemical products. Health & Safety Abroad (Crowding): U.S. ICE emails describe dangerous overcrowding and inadequate medical support at a New York detention site, including people with serious conditions left without proper care. Kidney Drug R&D: Dimerix says it has expanded its kidney pipeline, adding an acute kidney injury program tied to heart surgery patients, alongside its phase III FSGS study.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
